openPR Logo
Press release

Toronto-Based Artist Elgoba Drops Highly Anticipated EP Humble and Pray

11-15-2024 05:58 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

Toronto-Based Artist Elgoba Drops Highly Anticipated EP Humble

New Release Showcases a Fresh Blend of Dancehall, Afrobeat, and Urban Rhythms.
Nov 15, 2024 - Toronto, Canada - Toronto-based artist Elgoba proudly announces the release of his latest EP, Humble and Pray, a dynamic project that blends infectious beats with introspective lyrics and an unmistakable Caribbean flair. The eight track EP is now available on all major streaming platforms, offering fans a unique fusion of dancehall, Afrobeat, and urban influences that speaks to personal growth and resilience.

Elgoba describes Humble and Pray as a reflection of his journey, a project that acknowledges the importance of staying grounded and grateful while embracing the pursuit of dreams. The title track, "Humble and Pray," serves as a powerful anthem about resilience and remaining humble through life's challenges. "Feelings" takes a soulful dive into the complexities of love and vulnerability, while "Mama" pays heartfelt tribute to the unconditional love and sacrifice of mothers everywhere. With "Nah Beg," Elgoba delivers an empowering message about self-respect and independence, encouraging listeners to stand strong on their own.

Adding to the EP's energy, "Soccer Bunx" is a high-octane dance track that captures the spirit of celebration, while "Bum Bum" is a catchy tune celebrating confidence and the joy of self-expression. "Drip Drip" highlights personal flair and individuality with style and swagger, while the reflective "Intangible" brings it all together, reminding listeners of the intangible qualities that shape us.

Elgoba's roots in Toronto's vibrant music scene have helped him cultivate a sound that resonates with listeners worldwide. His lyrics, inspired by his personal experiences, provide a glimpse into his journey and offer an authentic yet universally appealing collection of songs. With a seamless blend of vibrant beats and meaningful storytelling, Humble and Pray reflects Elgoba's artistry, skill, and deep connection with his audience.

Already generating buzz for its fresh sound and memorable hooks, Humble and Pray has been praised by fans and critics alike for its authenticity and danceability. From introspective ballads to energetic anthems, the EP showcases Elgoba's range as both a songwriter and a performer, each track delivering something unique and engaging.

Humble and Pray is now streaming on platforms such as Spotify, Apple Music, and YouTube [https://www.youtube.com/playlist?list=OLAK5uy_nrWb7minHP4dKxKZnFjZyT5dcvG62BZzs], bringing Elgoba's distinctive style and powerful messages to listeners around the world.

About Elgoba

Based in Toronto, Canada, Elgoba is an emerging artist known for his blend of dancehall, Afrobeat, and urban influences. His music speaks to life's highs and lows with authenticity and style, making him one to watch in today's music scene.

Media Contact
Company Name: Elgoba
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=torontobased-artist-elgoba-drops-highly-anticipated-ep-humble-and-pray]
Country: Canada
Website: https://www.youtube.com/playlist?list=OLAK5uy_nrWb7minHP4dKxKZnFjZyT5dcvG62BZzs



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Toronto-Based Artist Elgoba Drops Highly Anticipated EP Humble and Pray here

News-ID: 3738752 • Views:

More Releases from ABNewswire

Plaque Psoriasis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics
Plaque Psoriasis Market Insights Highlight Expanding Outlook Till 2034, DelveIns …
The Key Plaque Psoriasis Companies in the market include - Dermavant Sciences GmbH, IQVIA Biotech, UCB Biopharma SRL, Parexel, Samsung Bioepis Co., Ltd, Durect, Astellas, Biogen, Dow Pharmaceutical Sciences, Shire, Zalicus, AbbVie, Santalis Pharmaceuticals Inc, Maruho Co Ltd, Novartis, AstraZeneca, Pfizer, and others. DelveInsight's "Plaque Psoriasis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis
Acute Myeloid Leukemia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | SystImmune, Jasper Therapeutics, Chimerix, Akeso Biopharma, Syros Pharma, TC Biopharm
Acute Myeloid Leukemia Market to Evolve Rapidly Over the Next Decade by 2034, De …
The Key Acute Myeloid Leukemia Companies in the market include - SystImmune, Jasper Therapeutics, Chimerix, Akeso Biopharma Co., Ltd., Syros Pharmaceuticals, TC Biopharm, Stemline Therapeutics, Orca Bio, Gilead Sciences, GlycoMimetics, and others. The Acute Myeloid Leukemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Myeloid Leukemia pipeline products will significantly revolutionize the Acute Myeloid Leukemia market dynamics. DelveInsight's
Pancreatic Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Bio, Keymed Biosciences, Carisma Therapeu
Pancreatic Cancer Market Positioned for Accelerated Development Through 2034, De …
The Key Pancreatic Cancer Companies in the market include - AstraZeneca, Merck Sharp & Dohme, Actuate Therapeutics, Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co.Ltd, Carisma Therapeutics Inc, Cue Biopharma, Bold Therapeutics, Purple Biotech Ltd, ENB Therapeutics, Gritstone bio, AstraZeneca, Candel Therapeutics, Alligator Bioscience, FibroGen, Novartis AG, AB Science, Eleison Pharmaceuticals, and others. The Pancreatic Cancer market is expected to surge due to the disease's increasing prevalence and
Hereditary Transthyretin Amyloidosis (hATTR) Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Eidos, Corino, Prothena, Ionis Pharma, AstraZeneca, Novo Nordisk
Hereditary Transthyretin Amyloidosis (hATTR) Market to Witness Promising Upswing …
The Key Hereditary Transthyretin Amyloidosis Companies in the market include - Alnylam Pharmaceuticals, AstraZeneca, Ionis Pharmaceuticals, Intellia Therapeutics, Neurimmune, Alexion Pharmaceuticals, Novo Nordisk, Eidos Therapeutics, Corino Therapeutics, Prothena, Regeneron Pharmaceutical, and others. DelveInsight's "Hereditary Transthyretin Amyloidosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hereditary Transthyretin Amyloidosis, historical and forecasted epidemiology as well as the Hereditary Transthyretin Amyloidosis market trends in the United States, EU4 (Germany,

All 5 Releases